Overview

  • Product nameGR 55562 dihydrochloride
  • Description
    Selective 5-HT1B / 5-HT1D receptor antagonist
  • Biological descriptionSelective, competitive 5-HT1B/ 5-HT1D receptor antagonist (pKi values are 7.4 and 6.2, respectively). Inhibits 5-HT evoked contraction in pulmonary resistance arteries (pEC10 = 7.26).
  • Purity> 99%

Properties

    References for GR 55562 dihydrochloride (ab120513)

    This product has been referenced in:
    • Maassen VanDenBrink A  et al. Human isolated coronary artery contraction to sumatriptan characterised by the selective 5-HT1B/1D receptor antagonist GR55562. Pharmacol Toxicol 86:287-90 (2000). Read more (PubMed: 10895993) »
    • Nilsson T  et al. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry. Br J Pharmacol 128:1133-40 (1999). Read more (PubMed: 10578124) »
    • Morecroft I & MacLean MR 5-hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries. Br J Pharmacol 125:69-78 (1998). Read more (PubMed: 9776346) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120513.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"